Scientific program

8.30

Opening

 

Session 1: Functional and morphological biomarkers of arterial damage

8.40

Atherosclerosis and arterial stiffness, parallel damage (J. Filipovský, Czech Republic)

9.10

Stem cells as a biomarker and treatment tool in peripheral artery disease (J. Maďarič, Slovak Republic)

9.40

How to detect unstable plaques (A. Nicolaides, UK)

10.10

Coffee break

 

Session 2: Non-LDL lipid biomarkers

10.30

Lp(a): still a prominent lipoprotein biomarker (Pia R. Kamstrup, Denmark)

11.00

Roles of HDL (cholesterol) in risk prediction and treatment decisions (A. von Eckardstein, Switzerland)

11.30

Oxidative stress markers and risk of vascular disease (M. Bobak, UK)

12.00

Non HDL-C: a better biomarker (than LDL-C) of CVD all the way from bench to bedside (A. Zambon, Italy)

12.30

Lunch

 

Session 3: Non-lipid biomarkers

13.30

Cholesterol and beta-cell function: the role of PCSK9-LDLR axis​ (D. Norata, Italy)

14.00

Genetics and epigenetics (J. Hubáček, Czech Republic)

14.30

Coffee break + Hands-on workshops

Duplex ultrasound detection of preclinical atherosclerosis (J. Pitha, Czech Republic)

Assessment of arterial stiffness (P. Wohlfahrt, Czech Republic)

Ultra High Frequency ultrasound in vascular imaging (D. Fuchs, Netherlands) 

 

Session 4: Management

15.30

How to lower blood pressure and the risk of atherosclerotic complications? (P. Nilsson, Sweden)

16.00

Lipid risk factors and their management in PAD (M. Vrablík, Czech Republic) 

16.30

How to lower glucose and the risk of atherosclerotic complications? (I. Pećin, Croatia)

 

 

Conflict of interest disclosures